Portage Biotech (PRTG) Short Interest Ratio & Short Volume $5.86 +0.02 (+0.34%) Closing price 07/3/2025 01:19 PM EasternExtended Trading$5.87 +0.01 (+0.15%) As of 07/3/2025 04:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Portage Biotech Short Interest DataPortage Biotech (PRTG) has a short interest of 8,800 shares, representing 3.20% of the float (the number of shares available for trading by the public). This marks a -45.68% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 995,116 shares to cover all short positions.Current Short Interest8,800 sharesPrevious Short Interest16,200 sharesChange Vs. Previous Month-45.68%Dollar Volume Sold Short$52.71 thousandShort Interest Ratio0.0 Days to CoverLast Record DateJune 15, 2025Outstanding Shares1,050,000 sharesFloat Size275,100 sharesShort Percent of Float3.20%Today's Trading Volume10,418 sharesAverage Trading Volume995,116 sharesToday's Volume Vs. Average1% Short Selling Portage Biotech? Sign up to receive the latest short interest report for Portage Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPRTG Short Interest Over TimePRTG Days to Cover Over TimePRTG Percentage of Float Shorted Over Time Portage Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/20258,800 shares $52.71 thousand -45.7%3.2%0 $5.99 5/31/202516,200 shares $127.49 thousand -67.3%5.9%0 $7.87 5/15/202549,600 shares $374.48 thousand -56.6%30.3%0 $7.55 4/30/2025114,400 shares $1.36 million -13.3%70.0%0.1 $11.85 4/15/2025131,900 shares $1.05 million -57.2%80.7%0.1 $7.99 3/31/2025308,400 shares $2.85 million +2,134.8%50.7%0.5 $9.25 3/15/202513,800 shares $58.10 thousand -20.7%8.4%0.2 $4.21 2/28/202517,400 shares $78.47 thousand +33.9%10.6%0 $4.51 2/15/202513,000 shares $59.93 thousand -43.0%8.0%0 $4.61 1/31/202522,800 shares $100.55 thousand +15.2%5.2%0 $4.41 Get the Latest News and Ratings for PRTG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Portage Biotech and its competitors with MarketBeat's FREE daily newsletter. 1/15/202519,800 shares $78.61 thousand -25.0%4.5%0 $3.97 12/31/202426,400 shares $136.49 thousand +175.0%6.0%0 $5.17 12/15/20249,600 shares $28.80 thousand +2.1%2.2%0 $3.00 11/30/20249,400 shares $39.34 thousand -6.9%2.2%0 $4.19 11/15/202410,100 shares $41.31 thousand -30.3%2.4%0 $4.09 10/31/202414,500 shares $82.36 thousand -22.9%3.4%0 $5.68 10/15/202418,800 shares $117.69 thousand +6.8%4.4%0 $6.26 9/30/202417,600 shares $117.04 thousand +87.2%4.2%0 $6.65 9/15/20249,400 shares $33.46 thousand -80.2%2.2%0 $3.56 8/31/202447,400 shares $163.53 thousand +558.3%11.2%0.1 $3.45 8/15/20247,200 shares $25.20 thousand -88.1%0.1%0 $3.50 7/31/202460,600 shares $10.67 thousand -75.0%0.7%0.1 $0.18 7/15/2024242,000 shares $43.56 thousand +1,628.6%2.8%0.3 $0.18 6/30/202414,000 shares $2.97 thousand -74.5%0.2%0 $0.21 6/15/202454,900 shares $13.73 thousand -9.3%0.6%0.2 $0.25 5/31/202460,500 shares $28.97 thousand +2.2%0.7%0.2 $0.48 5/15/202459,200 shares $15.13 thousand +2,473.9%0.7%0.3 $0.26 4/30/20242,300 shares $559.13 -72.6%0.0%0 $0.24 4/15/20248,400 shares $2.86 thousand +29.2%0.1%0.1 $0.34 3/31/20246,500 shares $3.66 thousand -57.8%0.1%0.1 $0.56 3/15/202415,400 shares $8.47 thousand -84.6%0.2%0.2 $0.55 2/29/2024100,200 shares $59.12 thousand +902.0%1.2%1.8 $0.59 2/15/202410,000 shares $6.01 thousand -9.1%0.1%0.2 $0.60 1/31/202411,000 shares $9.57 thousand +44.7%0.1%0.3 $0.87 1/15/20247,600 shares $8.21 thousand +16.9%0.1%0.2 $1.08 12/31/20236,500 shares $11.83 thousand -63.1%0.1%0.2 $1.82 12/15/202317,600 shares $22.35 thousand -25.4%0.2%0.5 $1.27 11/30/202323,600 shares $31.03 thousand -56.4%0.3%0.8 $1.32 11/15/202354,100 shares $78.45 thousand +4.4%0.7%2 $1.45 10/31/202351,800 shares $102.82 thousand -8.3%0.6%2.3 $1.99Banks aren’t ready for this altcoin—are you? (Ad)I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. This is about being in the right place at the right time – and I believe that time is now.Discover our #1 crypto for the red-hot crypto market right now! 10/15/202356,500 shares $119.78 thousand +4.2%0.7%2.5 $2.12 9/30/202354,200 shares $113.28 thousand +32.2%0.7%2.9 $2.09 9/15/202341,000 shares $118.49 thousand +494.2%0.5%2.9 $2.89 8/31/20236,900 shares $17.66 thousand -27.4%0.1%0.5 $2.56 8/15/20239,500 shares $22.80 thousand +30.1%0.1%0.7 $2.40 7/31/20237,300 shares $23.51 thousand +1.4%0.1%0.5 $3.22 7/15/20237,200 shares $24.41 thousand +22.0%0.1%0.5 $3.39 6/30/20235,900 shares $20.59 thousand -24.4%0.1%0.4 $3.49 6/15/20237,800 shares $28.86 thousand -1.3%0.1%0.4 $3.70 5/31/20237,900 shares $27.49 thousand -75.8%0.1%0.3 $3.48 5/15/202332,600 shares $104.65 thousand -10.4%0.4%1.3 $3.21 4/30/202336,400 shares $121.58 thousand -34.8%0.5%1.3 $3.34 4/15/202355,800 shares $175.77 thousand +5.5%0.7%1.7 $3.15 3/31/202352,900 shares $163.46 thousand +32.6%0.7%1.5 $3.09 3/15/202339,900 shares $119.70 thousand -6.8%0.5%1.1 $3.00 2/28/202342,800 shares $163.50 thousand -9.1%0.5%1.1 $3.82 2/15/202347,100 shares $198.76 thousand -3.1%0.4%1.3 $4.22 1/31/202348,600 shares $250.29 thousand +7.5%0.4%1.4 $5.15 1/15/202345,200 shares $246.15 thousand -11.2%0.3%1.7 $5.45 12/30/202250,900 shares $269.26 thousand +7.4%0.4%2.1 $5.29 12/15/202247,400 shares $237 thousand -0.8%0.4%2.3 $5.00 11/30/202247,800 shares $281.06 thousand +2.6%0.4%2.6 $5.88 11/15/202246,600 shares $280.07 thousand +2.4%0.4%3.2 $6.01 10/31/202245,500 shares $298.94 thousand -23.1%0.3%3.2 $6.57 10/15/202259,200 shares $400.19 thousand +11.1%0.9%3.9 $6.76 9/30/202253,300 shares $363.51 thousand +1.0%0.8%3.3 $6.82 9/15/202252,800 shares $414.48 thousand -23.6%0.8%2 $7.85 8/31/202269,100 shares $532.76 thousand +0.4%1.4%2.3 $7.71 8/15/202268,800 shares $580.67 thousand -12.1%1.4%1.9 $8.44 7/31/202278,300 shares $792.40 thousand +9.2%1.5%1.8 $10.12 7/15/202271,700 shares $646.02 thousand -6.0%1.4%1.6 $9.01 6/30/202276,300 shares $532.57 thousand -56.2%1.5%1.7 $6.98 6/15/2022174,100 shares $1.55 million -11.4%3.4%3.9 $8.93 5/31/2022196,500 shares $1.97 million -20.7%3.9%5.4 $10.00 5/15/2022247,900 shares $1.54 million +6.3%4.9%6.8 $6.20 4/30/2022233,200 shares $1.29 million +13.6%4.6%8.2 $5.54 4/15/2022205,300 shares $1.31 million +3.5%4.0%7.7 $6.39 3/31/2022198,400 shares $1.30 million +5.4%3.9%8.1 $6.57 3/15/2022188,200 shares $1.41 million +3.9%3.7%8.1 $7.51 2/28/2022181,100 shares $1.44 million +11.5%3.6%7.8 $7.95 2/15/2022162,400 shares $1.44 million +9.5%3.2%6.7 $8.84 1/31/2022148,300 shares $1.29 million +1.4%2.9%6 $8.68 1/15/2022146,200 shares $1.54 million +2.2%2.9%5.6 $10.54 12/31/2021143,100 shares $1.54 million +12.8%2.9%5.7 $10.73 12/15/2021126,900 shares $1.54 million +3.9%2.6%5.2 $12.13 11/30/2021122,200 shares $1.80 million -9.3%2.5%4.5 $14.73 11/15/2021134,700 shares $2.94 million -9.5%2.8%5.6 $21.86 10/29/2021148,800 shares $3.04 million +3.1%3.0%6.1 $20.40 10/15/2021144,400 shares $3.00 million -8.5%3.0%5.4 $20.79 9/30/2021157,800 shares $3.21 million +0.9%3.2%4.8 $20.32Banks aren’t ready for this altcoin—are you? (Ad)I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. This is about being in the right place at the right time – and I believe that time is now.Discover our #1 crypto for the red-hot crypto market right now! 9/15/2021156,400 shares $2.97 million -10.1%3.2%2.2 $18.97 8/31/2021174,000 shares $3.53 million -0.7%3.6%2.4 $20.31 8/13/2021175,200 shares $3.03 million No Change3.6%2.4 $17.32 PRTG Short Interest - Frequently Asked Questions What is Portage Biotech's current short interest? Short interest is the volume of Portage Biotech shares that have been sold short but have not yet been covered or closed out. As of June 15th, investors have sold 8,800 shares of PRTG short. 3.20% of Portage Biotech's shares are currently sold short. Learn More on Portage Biotech's current short interest. What is a good short interest percentage for Portage Biotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.20% of Portage Biotech's floating shares are currently sold short. Is Portage Biotech's short interest increasing or decreasing? Portage Biotech saw a decline in short interest during the month of June. As of June 15th, there was short interest totaling 8,800 shares, a decline of 45.7% from the previous total of 16,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Portage Biotech's float size? Portage Biotech currently has issued a total of 1,050,000 shares. Some of Portage Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Portage Biotech currently has a public float of 275,100 shares. How does Portage Biotech's short interest compare to its competitors? 3.20% of Portage Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Portage Biotech: FibroGen, Inc (5.10%), CalciMedica Inc. (1.73%), Chemomab Therapeutics Ltd. Sponsored ADR (1.04%), Elevation Oncology, Inc. (5.74%), Relmada Therapeutics, Inc. (2.64%), Ovid Therapeutics (4.20%), NanoViricides, Inc. (0.59%), DURECT Corporation (2.90%), Lisata Therapeutics, Inc. (0.46%), Finch Therapeutics Group, Inc. (0.10%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Portage Biotech stock? Short selling PRTG is an investing strategy that aims to generate trading profit from Portage Biotech as its price is falling. PRTG shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Portage Biotech? A short squeeze for Portage Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PRTG, which in turn drives the price of the stock up even further. How often is Portage Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PRTG, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies FGEN Short Squeeze CALC Short Squeeze CMMB Short Squeeze ELEV Short Squeeze RLMD Short Squeeze OVID Short Squeeze NNVC Short Squeeze DRRX Short Squeeze LSTA Short Squeeze FNCH Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PRTG) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Portage Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Portage Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
